Class- and isoform-specific HDAC inhibitors and uses thereof
US9540317B2 · kind B2 · utility
2Cited by
84References
39Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 6, 2014 |
| Grant date | Jan 10, 2017 |
| Priority date | — |
| Expiry date | May 6, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is drawn to compounds of Formula (I) below:and the pharmaceutically acceptable salts thereof, wherein R and R″ are defined herein. The compounds are useful inhibitors of histone deacetylases (HDAC).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.